ABTS vs ICU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

ABTS

39.7
AI Score
VS
ICU Wins

ICU

49.1
AI Score

Investment Advisor Scores

ABTS

40score
Recommendation
AVOID NEW MONEY

ICU

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABTS ICU Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -20.0% 82.0% ICU
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 39.7/100 49.1/100 ICU
Profit Margin -60.8% 0.0% ICU
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD ICU

Relative Price Performance (Last 90 Days)

ABTS 1M: -69.3% · 3M: -70.0% ICU 1M: -46.1% · 3M: -49.1%

Current Technical Phase

ABTS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.2%), weak momentum, RSI 15

RSI (14): 14.9 · Price: $0.38

ICU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.3%), weak momentum, RSI 31

RSI (14): 31.2 · Price: $1.88

Fundamentals Snapshot

Metric ABTS ICU
Market Cap — —
Forward P/E 0.0 -0.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.2% 0.8%
Gross Margin 0.2% 0.9%
Operating Margin -0.7% -6.2%
EPS -1.78 -2.97
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ICU is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.